1 Mason, S. B. et al. The biomarker enriched proteome of autosomal dominant polycystic kidney disease cyst fluid. Proteomics Clin Appl3, 1247-1250, doi:10.1002/prca.200800163 (2009).
2 Grantham, J. J., Mulamalla, S. & Swenson-Fields, K. I. Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol7, 556-566, doi:10.1038/nrneph.2011.109 (2011).
3 Lanktree, M. B. et al. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing. J Am Soc Nephrol29, 2593-2600, doi:10.1681/asn.2018050493 (2018).
4 Cadnapaphornchai, M. A. Autosomal dominant polycystic kidney disease in children. Curr Opin Pediatr27, 193-200, doi:10.1097/mop.0000000000000195 (2015).
5 Bastos, A. P. & Onuchic, L. F. Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease. Braz J Med Biol Res44, 606-617, doi:10.1590/s0100-879x2011007500068 (2011).
6 Cornec-Le Gall, E., Torres, V. E. & Harris, P. C. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases. J Am Soc Nephrol29, 13-23, doi:10.1681/asn.2017050483 (2018).
7 Bergmann, C. et al. Polycystic kidney disease. Nat Rev Dis Primers4, 50, doi:10.1038/s41572-018-0047-y (2018).
8 Viau, A. et al. Tubular STAT3 Limits Renal Inflammation in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol31, 1035-1049, doi:10.1681/asn.2019090959 (2020).
9 Irazabal, M. V. et al. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol26, 160-172, doi:10.1681/asn.2013101138 (2015).
10 Cornec-Le Gall, E. et al. Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial. Nephrol Dial Transplant33, 645-652, doi:10.1093/ndt/gfx188 (2018).
11 Kistler, A. D. et al. Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study. PLoS One8, e53016, doi:10.1371/journal.pone.0053016 (2013).
12 Silver, N., Best, S., Jiang, J. & Thein, S. L. Selection of housekeeping genes for gene expression studies in human reticulocytes using real-time PCR. BMC Mol Biol7, 33, doi:10.1186/1471-2199-7-33 (2006).
13 Nakao, R., Yamamoto, S., Yasumoto, Y., Kadota, K. & Oishi, K. Impact of denervation-induced muscle atrophy on housekeeping gene expression in mice. Muscle Nerve51, 276-281, doi:10.1002/mus.24310 (2015).
14 Sellayah, D., Sek, K., Anthony, F. W., Hanson, M. A. & Cagampang, F. R. Sensitivity of housekeeping genes in the hypothalamus to mismatch in diets between pre- and postnatal periods in mice. Neurosci Lett447, 54-57, doi:10.1016/j.neulet.2008.09.060 (2008).
15 Radonić, A. et al. Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun313, 856-862, doi:10.1016/j.bbrc.2003.11.177 (2004).
16 Wang, K. et al. Molecular engineering of DNA: molecular beacons. Angew Chem Int Ed Engl48, 856-870, doi:10.1002/anie.200800370 (2009).
17 Manzano, R. et al. Housekeeping gene expression in myogenic cell cultures from neurodegeneration and denervation animal models. Biochem Biophys Res Commun407, 758-763, doi:10.1016/j.bbrc.2011.03.096 (2011).
18 Liu, D. et al. Identification of Key Genes and Candidated Pathways in Human Autosomal Dominant Polycystic Kidney Disease by Bioinformatics Analysis. Kidney Blood Press Res44, 533-552, doi:10.1159/000500458 (2019).
19 Lu, S., Gu, X., Hoestje, S. & Epner, D. E. Identification of an additional hypoxia responsive element in the glyceraldehyde-3-phosphate dehydrogenase gene promoter. Biochim Biophys Acta1574, 152-156, doi:10.1016/s0167-4781(01)00359-1 (2002).
20 Dioudis, C., Dimitrios, G., Thomas, T. H. & West, I. C. Abnormal glyceraldehyde-3-phosphate dehydrogenase binding and glycolytic flux in Autosomal Dominant Polycystic Kidney Disease after a mild oxidative stress. Hippokratia12, 162-167 (2008).
21 Muñoz, J. J. et al. Identification of housekeeping genes for microRNA expression analysis in kidney tissues of Pkd1 deficient mouse models. Sci Rep10, 231, doi:10.1038/s41598-019-57112-4 (2020).
22 Vandesompele, J. et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol3, RESEARCH0034, doi:10.1186/gb-2002-3-7-research0034 (2002).
23 Chen, W. C., Tzeng, Y. S. & Li, H. Gene expression in early and progression phases of autosomal dominant polycystic kidney disease. BMC Res Notes1, 131, doi:10.1186/1756-0500-1-131 (2008).
24 Hama, T. et al. Aberrant Smad3 phosphoisoforms in cyst-lining epithelial cells in the. Am J Physiol Renal Physiol313, F1223-F1231, doi:10.1152/ajprenal.00697.2016 (2017).
25 Sato, Y., Yamamura, M., Sasaki, M. & Harada, K. Blockade of Hedgehog Signaling Attenuates Biliary Cystogenesis in the Polycystic Kidney (PCK) Rat. Am J Pathol188, 2251-2263, doi:10.1016/j.ajpath.2018.06.014 (2018).
26 Harris, P. C. & Torres, V. E. Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest124, 2315-2324, doi:10.1172/jci72272 (2014).
27 Menezes, L. F. & Germino, G. G. Murine Models of Polycystic Kidney Disease. Drug Discov Today Dis Mech10, e153-e158, doi:10.1016/j.ddmec.2013.10.002 (2013).
28 Rogers, K. A. et al. Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD. Physiol Rep4, doi:10.14814/phy2.12846 (2016).
29 Wang, S., Wang, B., He, H., Sun, A. & Guo, C. A new set of reference housekeeping genes for the normalization RT-qPCR data from the intestine of piglets during weaning. PLoS One13, e0204583, doi:10.1371/journal.pone.0204583 (2018).
30 Breyer, M. D. & Susztak, K. The next generation of therapeutics for chronic kidney disease. Nat Rev Drug Discov15, 568-588, doi:10.1038/nrd.2016.67 (2016).
31 Cui, X., Zhou, J., Qiu, J., Johnson, M. R. & Mrug, M. Validation of endogenous internal real-time PCR controls in renal tissues. Am J Nephrol30, 413-417, doi:10.1159/000235993 (2009).
32 Leal, M. F. et al. Comprehensive selection of reference genes for expression studies in meniscus injury using quantitative real-time PCR. Gene584, 60-68, doi:10.1016/j.gene.2016.03.005 (2016).
33 Dupasquier, S. et al. Validation of housekeeping gene and impact on normalized gene expression in clear cell renal cell carcinoma: critical reassessment of YBX3/ZONAB/CSDA expression. BMC Mol Biol15, 9, doi:10.1186/1471-2199-15-9 (2014).
34 Olsan, E. E. et al. Signal transducer and activator of transcription-6 (STAT6) inhibition suppresses renal cyst growth in polycystic kidney disease. Proc Natl Acad Sci U S A108, 18067-18072, doi:10.1073/pnas.1111966108 (2011).
35 Ma, Y., Dai, H., Kong, X. & Wang, L. Impact of thawing on reference gene expression stability in renal cell carcinoma samples. Diagn Mol Pathol21, 157-163, doi:10.1097/PDM.0b013e31824d3435 (2012).
36 Caracausi, M. et al. Systematic identification of human housekeeping genes possibly useful as references in gene expression studies. Mol Med Rep16, 2397-2410, doi:10.3892/mmr.2017.6944 (2017).
37 Li, C. et al. Expression of PGAM1 in renal clear cell carcinoma and its clinical significance. Int J Clin Exp Pathol8, 9410-9415 (2015).
38 Fonseca, J. M. et al. Renal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1-deficient mice. Kidney Int85, 1137-1150, doi:10.1038/ki.2013.501 (2014).
39 Schmid, H. et al. Validation of endogenous controls for gene expression analysis in microdissected human renal biopsies. Kidney Int64, 356-360, doi:10.1046/j.1523-1755.2003.00074.x (2003).
40 Gholami, K., Loh, S. Y., Salleh, N., Lam, S. K. & Hoe, S. Z. Selection of suitable endogenous reference genes for qPCR in kidney and hypothalamus of rats under testosterone influence. PLoS One12, e0176368, doi:10.1371/journal.pone.0176368 (2017).
41 Bustin, S. A. & McKay, I. A. The product of the primary response gene BRF1 inhibits the interaction between 14-3-3 proteins and cRaf-1 in the yeast trihybrid system. DNA Cell Biol18, 653-661, doi:10.1089/104454999315060 (1999).
42 Cale, J. M., Millican, D. S., Itoh, H., Magness, R. R. & Bird, I. M. Pregnancy induces an increase in the expression of glyceraldehyde-3-phosphate dehydrogenase in uterine artery endothelial cells. J Soc Gynecol Investig4, 284-292 (1997).
43 Puissant, C., Bayat-Sarmadi, M., Devinoy, E. & Houdebine, L. M. Variation of transferrin mRNA concentration in the rabbit mammary gland during the pregnancy-lactation-weaning cycle and in cultured mammary cells. A comparison with the other major milk protein mRNAs. Eur J Endocrinol130, 522-529, doi:10.1530/eje.0.1300522 (1994).
44 Calvo, E. L., Boucher, C., Coulombe, Z. & Morisset, J. Pancreatic GAPDH gene expression during ontogeny and acute pancreatitis induced by caerulein. Biochem Biophys Res Commun235, 636-640, doi:10.1006/bbrc.1997.6716 (1997).
45 Mansur, N. R., Meyer-Siegler, K., Wurzer, J. C. & Sirover, M. A. Cell cycle regulation of the glyceraldehyde-3-phosphate dehydrogenase/uracil DNA glycosylase gene in normal human cells. Nucleic Acids Res21, 993-998, doi:10.1093/nar/21.4.993 (1993).
46 Sikand, K., Singh, J., Ebron, J. S. & Shukla, G. C. Housekeeping gene selection advisory: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin are targets of miR-644a. PLoS One7, e47510, doi:10.1371/journal.pone.0047510 (2012).
47 Glare, E. M., Divjak, M., Bailey, M. J. & Walters, E. H. beta-Actin and GAPDH housekeeping gene expression in asthmatic airways is variable and not suitable for normalising mRNA levels. Thorax57, 765-770, doi:10.1136/thorax.57.9.765 (2002).
48 Nazari, F., Parham, A. & Maleki, A. F. GAPDH, β-actin and β2-microglobulin, as three common reference genes, are not reliable for gene expression studies in equine adipose- and marrow-derived mesenchymal stem cells. J Anim Sci Technol57, 18, doi:10.1186/s40781-015-0050-8 (2015).
49 Araujo, L. C. C., Bordin, S. & Carvalho, C. R. O. Reference Gene and Protein Expression Levels in Two Different NAFLD Mouse Models. Gastroenterol Res Pract2020, 1093235, doi:10.1155/2020/1093235 (2020).
50 Zhou, S. M. et al. β-actin gene expression is variable among individuals and not suitable for normalizing mRNA levels in Portunus trituberculatus. Fish Shellfish Immunol81, 338-342, doi:10.1016/j.fsi.2018.07.021 (2018).
51 Weimbs, T., Shillingford, J. M., Torres, J., Kruger, S. L. & Bourgeois, B. C. Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease. Clin Kidney J11, i27-i38, doi:10.1093/ckj/sfy089 (2018).
52 Talbot, J. J. et al. Polycystin-1 regulates STAT activity by a dual mechanism. Proc Natl Acad Sci U S A108, 7985-7990, doi:10.1073/pnas.1103816108 (2011).
53 Weimbs, T. & Talbot, J. J. STAT3 Signaling in Polycystic Kidney Disease. Drug Discov Today Dis Mech10, e113-e118, doi:10.1016/j.ddmec.2013.03.001 (2013).
54 Takakura, A. et al. Pyrimethamine inhibits adult polycystic kidney disease by modulating STAT signaling pathways. Hum Mol Genet20, 4143-4154, doi:10.1093/hmg/ddr338 (2011).
55 Leonhard, W. N. et al. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model. Am J Physiol Renal Physiol300, F1193-1202, doi:10.1152/ajprenal.00419.2010 (2011).
56 Nowak, K. L. & Hopp, K. Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential. Clin J Am Soc Nephrol15, 577-584, doi:10.2215/cjn.13291019 (2020).
57 Malas, T. B. et al. Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles. EBioMedicine51, 102585, doi:10.1016/j.ebiom.2019.11.046 (2020).
58 Piontek, K. B. et al. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J Am Soc Nephrol15, 3035-3043, doi:10.1097/01.Asn.0000144204.01352.86 (2004).
59 Shillingford, J. M., Piontek, K. B., Germino, G. G. & Weimbs, T. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1. J Am Soc Nephrol21, 489-497, doi:10.1681/asn.2009040421 (2010).
60 Balbo, B. E. et al. Cardiac dysfunction in Pkd1-deficient mice with phenotype rescue by galectin-3 knockout. Kidney Int90, 580-597, doi:10.1016/j.kint.2016.04.028 (2016).
61 Bastos, A. P. et al. Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion. J Am Soc Nephrol20, 2389-2402, doi:10.1681/asn.2008040435 (2009).
62 Yu, S. et al. Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure. Proc Natl Acad Sci U S A104, 18688-18693, doi:10.1073/pnas.0708217104 (2007).
63 Andersen, C. L., Jensen, J. L. & Ørntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res64, 5245-5250, doi:10.1158/0008-5472.Can-04-0496 (2004).
64 Pfaffl, M. W., Tichopad, A., Prgomet, C. & Neuvians, T. P. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper--Excel-based tool using pair-wise correlations. Biotechnol Lett26, 509-515, doi:10.1023/b:bile.0000019559.84305.47 (2004).
65 Xie, F., Xiao, P., Chen, D., Xu, L. & Zhang, B. miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol Biol, doi:10.1007/s11103-012-9885-2 (2012).
66 Mukaka, M. M. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med J24, 69-71 (2012).